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Psychoanalysis is under greater attack than ever before. An unprecedented 
decommissioning of psychoanalytic services has taken place across the United 
Kingdom’s National Health Service (for example, Forest House NHS Psychotherapy 
Clinic), justified by cost savings. What are the reasons for this attack and what can 
be said in psychoanalysis’s defence? 
It has been claimed, perhaps fairly, that psychoanalysis and psychodynamic 
psychotherapies have failed to promote a culture of systematic evaluation and that 
the outcomes are difficult to measure and demonstrate. Relative to the number of 
studies on the effectiveness of cognitive behavioural therapy, few adequate studies 
are available of psychodynamic therapy outcomes. A growing body of studies, 
however, report that psychodynamic therapy is effective in the treatment of both mild 
and complex mental health problems. For example, a meta-analysis found 
substantial effect sizes in randomised controlled trials of long term psychodynamic 
psychotherapy, larger than those for short term therapies.[1] Positive correlations 
were also seen between outcome and duration or dosage of therapy. Another meta-
analysis found that psychotherapy in addition to antidepressants significantly 
reduced depressive symptoms compared with antidepressants alone.[2] A third 
meta-analysis found that short term psychodynamic psychotherapy may be more 
effective than other therapies for somatic disorders.[3] So evidence is on its way. 
Convergent support for psychoanalytic approaches comes from 20 studies of brain 
function changes after a range of psychotherapeutic treatments, including 
psychodynamic ones, for several mental disorders.[4] Brain changes that have been 
shown include a substantial increase in 5-HT1A receptor density in patients with 
major depressive disorder after psychodynamic therapy—this was not the case in 
patients who received fluoxetine[5]—and normalisation of neuronal activity in 
patients with somatoform disorders.[6] Ultimately these investigations will enable us 
to better understand the therapeutic mechanisms of a range of approaches and 
provide badly needed improvements in our treatments of complex disorders. 
The psychoanalytic approach makes three valuable and unique contributions to a 
modern healthcare economy. First, in their applied form, psychoanalytic ideas can 
support mental health staff to provide high quality services despite the interpersonal 
pressures to which they are inevitably exposed when working with disturbed and 
disturbing patients. Psychoanalytic understanding helps us to respond in humane 
ways when anxiety and stress threaten our ability to contemplate behaviour in terms 
of underlying mental states. The framework psychoanalysis provides for 
understanding why things go wrong in therapeutic relationships draws on a well-
developed theory of interactional process.[7] There are few viable alternative models 
for how a disturbed individual or community can affect the thinking and behaviour of 
those engaged with them. 
Secondly, there are increasingly strong indications that adult mental health problems 
are developmental in nature; three quarters can be traced back to mental health 
difficulties in childhood, and 50% arise before age 14 years.[8] The psychoanalytic 
model is unique in proposing a developmental theory (of attachment relationships) 
that is now firmly supported by evidence.[9] It therefore allows us to understand the 
relationship between early experience, genetic inheritance, and adult 
psychopathology. This developmental framework emphasises early intervention and 
has been critical in shaping positive mental health policy, including the UK 
government’s “No Health Without Mental Health” strategy.[10] Acknowledging the 
developmental, relational foundations of mental health also has important 
implications for prevention. 
Thirdly, psychoanalytical ideas continue to provide the foundations for a wide range 
of applied interventions. Research and clinical observation show that other 
modalities— particularly cognitive behavioural therapy—have made use of 
theoretical and clinical features of the psychoanalytic approach and incorporated 
these into their techniques. This may well enhance the overall effectiveness of these 
modalities; for example, some evidence suggests that the good outcomes achieved 
by other therapies correlate with the extent to which those therapies use 
psychodynamic techniques.[11] 
Research clearly shows that there is no one size fits all approach to the treatment of 
mental health problems; irrespective of brand, psychotherapy only substantially 
helps around 50% of referred patients who complete treatment[12] and medication 
fares no better.[13] Rationally designed services should therefore provide a range of 
approaches for which some evidence of effectiveness exists, and should continue to 
broaden the research base to ensure monitoring and improvement of the 
effectiveness of these services. More comprehensively, perhaps, than any other 
theory of the mind, psychoanalysis points to key psychological phenomena and 
processes (such as the limitations of consciousness, defences, resistance to 
treatment, transference and countertransference). These have to be integrated into 
our understanding of clinical work if adequate and effective psychological treatment 
is to be offered. If psychoanalysis is thrown out, these aspects of the mind will have 
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